Qc Cool And Heat Roll-on
NDC Package 63868-105-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Qc Cool And Heat Roll-on is a . Marketed by Chain Drug Marketing Association Inc, this product is identified by NDC 63868-105 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
63868-105-02
Package Description
71 g in 1 BOTTLE
Product Code
63868-105
11-Digit Billing Format
63868010502

Clinical Specifications

Proprietary Name
Qc Cool And Heat Roll-on
Dosage Form
-

Regulatory & Marketing

Labeler Name
Chain Drug Marketing Association Inc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
12-16-2021
End Marketing Date
12-16-2021
Listing Expiration
12-16-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63868-105-02 identifies a specific commercial package of 71 g in 1 bottle of Qc Cool And Heat Roll-on, labeled by Chain Drug Marketing Association Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association Inc on December 16, 2021. The current certification is valid through December 16, 2021.

How is this Chain Drug Marketing Association Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868010502. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63868-105-02
11-Digit CMS (5-4-2)
63868-0105-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.